Radiomics for predicting grades, isocitrate dehydrogenase mutation, and oxygen 6-methylguanine-DNA methyltransferase promoter methylation of adult diffuse gliomas: combination of structural MRI, apparent diffusion coefficient, and susceptibility-weighted imaging

Abstract excerpt

Background: ) mutation, and oxygen 6-methylguanine-DNA methyltransferase (MGMT) promoter methylation in patients with diffuse gliomas. Methods: test were used for assessing the statistical differences in patients' clinical characteristics. Delong test was performed to compare the areas under the curve (AUCs) of different radiomics models. Results: For WHO Grade task, the combined model of structural MRI, ADC, and...

Topics

Join the communities discussing this publication.

• Glioma Diagnosis and Treatment
• MRI in cancer diagnosis
• Radiomics and Machine Learning in Medical Imaging